Currently, using the above in silico panel from WES of 58 genes, a total of 4 patients with MODY 2 and 2 patients with MODY 3 were respectively identified to carry known pathogenic variants in the GCK and the HNF1A genes (unpublished data). This evidence concerns the gene HNF1A and MODY.